https://orcid.org/0000-0003-2258-2120
About the Authors
- Julie Aarestrup
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Writing – original draft, Writing – review & editing
* E-mail: Julie.Aarestrup@regionh.dk
Affiliation Center for Clinical Research and Prevention, Copenhagen University Hospital—Bispebjerg and Frederiksberg, Frederiksberg, Denmark
- Kim Blond
-
Roles Investigation, Writing – review & editing
Affiliation Center for Clinical Research and Prevention, Copenhagen University Hospital—Bispebjerg and Frederiksberg, Frederiksberg, Denmark
- Dorte Vistisen
-
Roles Investigation, Methodology, Software, Writing – review & editing
Affiliations Steno Diabetes Center Copenhagen, Herlev, Denmark, Department of Public Health, University of Copenhagen, Copenhagen K, Denmark
- Marit E. Jørgensen
-
Roles Investigation, Writing – review & editing
Affiliations Steno Diabetes Center Copenhagen, Herlev, Denmark, Steno Diabetes Center Greenland, Nuuk, Greenland, National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark
- Marie Frimodt-Møller
-
Roles Investigation, Writing – review & editing
Affiliation Steno Diabetes Center Copenhagen, Herlev, Denmark
- Britt W. Jensen
-
Roles Investigation, Methodology, Software, Writing – review & editing
Affiliation Center for Clinical Research and Prevention, Copenhagen University Hospital—Bispebjerg and Frederiksberg, Frederiksberg, Denmark
- Jennifer L. Baker
-
Roles Conceptualization, Data curation, Investigation, Methodology, Software, Validation, Writing – review & editing
Affiliation Center for Clinical Research and Prevention, Copenhagen University Hospital—Bispebjerg and Frederiksberg, Frederiksberg, Denmark
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: DV and MEJ have received research grants from Sanofi Aventis, Novo Nordisk A/S and Boehringer Ingelheim and DV also from Bayer A/S and MEJ also from AMGEN and Astra Zeneca. DV holds shares in Novo Nordisk A/S.